Metadata
- Name
- CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT05168423
- Description
- This is an open-label phase 1 study to assess the safety and feasibility of autologous T
cells co-expressing two CARs targeting the cryptic EGFR epitope 806 and IL13Ra2 (referred to
as "CART-EGFR-IL13Ra2 cells") in patients with EGFR-amplified glioblastoma, IDH-wildtype that
has recurred following prior radiotherapy. - Data or Study Types
- clinical trial
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2021
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT05168423
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT05168423